By Ruchika Sharma
Copyright medicaldialogues
Mumbai: Procter & Gamble Health Limited has appointed Shashank Srowthy as Chief Financial Officer (CFO) of the Company and Additional (Executive) Director effective October 1, 2025. His appointment is subject to the allotment of a Director Identification Number by the Ministry of Corporate Affairs.Srowthy succeeds Lokesh Chandak, who will step down as Director & CFO effective close of business hours of September 30, 2025, as he will be moving onto his new assignment in P&G as Senior Director – Finance & Accounting, Feminine Care- Asia Pacific Enterprise Markets, Middle East and Africa.Shashank Srowthy is a Bachelor of Electronics & Telecommunication Engineering from Pune University and a Master of Management Studies from Jamnalal Bajaj Institute of Management Studies. Shashank brings a diverse and rich experience in various finance roles across a career spanning 14 years. He joined P&G in 2011 in the India and has since worked across various roles and geographies delivering outstanding results for several P&G businesses across India, Dubai and Singapore. Shashank Srowthy will hold office as Additional Director up to the ensuing Annual General Meeting. Appointment of Shashank Srowthy as Executive Director is subject to approval of Central Government, in accordance with Section 196 of the Companies Act, 2013 read with Schedule V to the Act and approval of the Shareholders of the Company.Read also: P&G Health, HelpAge India collaborate to introduce Mobile Healthcare Unit in PalgharProcter & Gamble Health Limited was set up in India as one of Merck’s Asian subsidiaries in 1967. It was also the first Merck Group Company to go public in the year 1981. Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country.Read also: P&G Health partners with Indian Medical Association for launch of VitaM.I.N.D.S conclave
